breast cancer Archive — Page 11 of 16
-
July 13, 2017
Arteaga to direct UT Southwestern cancer center
Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies (C2T2), director of the Breast Cancer Research Program and associate director for Clinical Research at Vanderbilt-Ingram Cancer Center (VICC), has been named director of the Harold C. Simmons Comprehensive Cancer Center and associate dean of Oncology Programs at the UT Southwestern Medical Center in Dallas. -
June 19, 2017
STINGing combination for cancer
A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer. -
May 31, 2017
The Cancer Checklist
-
May 31, 2017
Journal Watch
-
May 30, 2017
News Around the Cancer Center
-
May 30, 2017
Cancer sleuths span the globe tracking down a prolific killer
-
April 20, 2017
Study examines new breast cancer drug combination
A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests a drug combination which includes a PDK1 protein blocker may be more effective for breast cancer that has become resistant to cyclin-dependent kinase (CDK4/6) targeted therapy.